Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients – An Observational Study

Andrew Ip, Donald A. Berry, Eric Hansen, Andre H. Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M. Berry, Nicholas S. Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L. Timmapuri, Joseph P. Underwood, Gregory Sugalski, Carol Barsky, Daniel W. Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
doi: https://doi.org/10.1101/2020.05.21.20109207

Article Information

doi 
https://doi.org/10.1101/2020.05.21.20109207
History 
  • May 25, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Andrew Ip, M.D. M.S.1,
  2. Donald A. Berry, Ph.D.2,3,
  3. Eric Hansen, B.S. M.S.4,
  4. Andre H. Goy, M.D.5,
  5. Andrew L Pecora, M.D.5,
  6. Brittany A Sinclaire, M.S.5,
  7. Urszula Bednarz, B.S CCRP5,
  8. Michael Marafelias, B.S.5,
  9. Scott M. Berry, Ph.D.2,
  10. Nicholas S. Berry, Ph.D.2,
  11. Shivam Mathura, B.A.4,
  12. Ihor S Sawczuk, M.D.6,
  13. Noa Biran, M.D.5,
  14. Ronaldo C Go, M.D.6,
  15. Steven Sperber, M.D.6,
  16. Julia A Piwoz, M.D.6,
  17. Bindu Balani, M.D.6,
  18. Cristina Cicogna, M.D.6,
  19. Rani Sebti, M.D.6,
  20. Jerry Zuckerman, M.D.6,
  21. Keith M Rose, M.D.6,
  22. Lisa Tank, M.D.6,
  23. Laurie G Jacobs, M.D.6,
  24. Jason Korcak, M.D.6,
  25. Sarah L. Timmapuri, M.D.6,
  26. Joseph P. Underwood, M.D.6,
  27. Gregory Sugalski, M.D.6,
  28. Carol Barsky, M.D.6,
  29. Daniel W. Varga, M.D.6,
  30. Arif Asif, M.D.6,
  31. Joseph C Landolfi, D.O.6 and
  32. Stuart L Goldberg, M.D.1,*
  1. 1Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack NJ (A.I, S.L.G)
  2. 2Berry Consultants LLC, Austin TX (D.A.B., S.M.B., N.S.B)
  3. 3M.D. Anderson Cancer Center of the University of Texas (D.A.B.)
  4. 4COTA, Boston MA (E.H., S.M.)
  5. 5John Theurer Cancer Center at Hackensack University Medical Center, Hackensack NJ (A.H.G., A.L.P., B.A.S., U.B., M.M., N.B.)
  6. 6Hackensack Meridian Health, Hackensack NJ and Hackensack Meridian School of Medicine at Seton Hall University, Nutley NJ (I.S.S, R.C.G., S.S., J.A.P., B.B., C.C., R.S., J.Z., K.M.R., L.T., L.G.J., J.K., S.L.T., J.P.U., G.S, C.B., D.W.V., A.A., J.L.)
  1. ↵*Corresponding Author: Stuart L. Goldberg, MD, John Theurer Cancer Center at Hackensack University Medical Center 92 Second Street, Hackensack NJ 07601 email: Stuart.Goldberg{at}hackensackmeridian.org
Back to top
Posted May 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients – An Observational Study
Andrew Ip, Donald A. Berry, Eric Hansen, Andre H. Goy, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Scott M. Berry, Nicholas S. Berry, Shivam Mathura, Ihor S Sawczuk, Noa Biran, Ronaldo C Go, Steven Sperber, Julia A Piwoz, Bindu Balani, Cristina Cicogna, Rani Sebti, Jerry Zuckerman, Keith M Rose, Lisa Tank, Laurie G Jacobs, Jason Korcak, Sarah L. Timmapuri, Joseph P. Underwood, Gregory Sugalski, Carol Barsky, Daniel W. Varga, Arif Asif, Joseph C Landolfi, Stuart L Goldberg
medRxiv 2020.05.21.20109207; doi: https://doi.org/10.1101/2020.05.21.20109207
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area